hg healthgevity bpc-157+ kpv+pea 500 BPC + PEA — Diverse Health BPC+PEA 500 – Healthgevity
Description
A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
Legal status (US): Ipamorelin is not FDA-approved for any human indication
Treat every efficacy statement here as studies suggest or in animal models, never as established human benefit
Notably, BPC157 accelerates burn wound healing after flame exposure [4], and our prior studies in thermal/incisional injury models implicate its proangiogenic activity as a central reparative mechanism [9]
